Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)
NCT01437111
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet
Sponsor
Organon and Co